High quality iPSC-derived human cells for drug discovery and cell-based therapies
Recently Released Cells
TrailBio® Hematopoietic Progenitor Cells
Our TrailBio® Hematopoietic Progenitor Cells (HPCs) are suitable for differentiation into multiple blood lineages, including erythroid and myeloid pathways, making them ideal for applications such as disease modeling, drug discovery and toxicology studies.
TrailBio® A9 Dopaminergic Neurons
Our TrailBio® A9 Dopaminergic Neurons represent a highly specialized subtype of midbrain neurons, crucial for motor control. Implicated in the pathology of Parkinson’s disease, A9 dopaminergic neurons are critically important for understanding neurodegeneration.
Powered by HD-DoE®
Pioneering Precision in Cellular Differentiation
Trailhead Biosystems® utilizes the High-Dimensional Design-of-Experiments (HD-DoE®) platform to revolutionize cellular research. This advanced method allows us to efficiently explore and optimize cell growth and differentiation processes. By analyzing multiple variables together, HD-DoE accelerates our development of precise cellular therapies and products. It’s a cornerstone of our approach to advancing regenerative medicine and personalized healthcare, enabling us to make significant breakthroughs in biotechnology.
Trailhead Events
We're Hiring!
If you want to make a difference in the life sciences, you have come to the right place! As a rapidly expanding and evolving biotech company, we are seeking individuals who are highly adaptable, possess unwavering integrity, and have ambitious career goals. If that sounds like you, follow the link below to become a Trailblazer!
